4-(4-Nitrophenyl)piperazin-1-ylethylamine → 5-(Furan-2-yl)-3-{2-[4-(4-nitrophenyl)piperazin-1-yl]ethyl}aminomethyl-1-phenylpyrazole
반응식
[N+:1]([C:4]1[CH:9]=[CH:8][C:7]([N:10]2[CH2:15][CH2:14][N:13]([CH2:16][CH2:17][NH2:18])[CH2:12][CH2:11]2)=[CH:6][CH:5]=1)([O-:3])=[O:2].[C:19]1([N:25]2[C:29]([C:30]3[O:31][CH:32]=[CH:33][CH:34]=3)=[CH:28][C:27]([CH:35]=O)=[N:26]2)[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=1>>[O:31]1[CH:32]=[CH:33][CH:34]=[C:30]1[C:29]1[N:25]([C:19]2[CH:20]=[CH:21][CH:22]=[CH:23][CH:24]=2)[N:26]=[C:27]([CH2:35][NH:18][CH2:17][CH2:16][N:13]2[CH2:12][CH2:11][N:10]([C:7]3[CH:6]=[CH:5][C:4]([N+:1]([O-:3])=[O:2])=[CH:9][CH:8]=3)[CH2:15][CH2:14]2)[CH:28]=1참가 물질
3
실험 절차
Compound 54 was prepared using the same method as that of Example 1 except that 4-(4-nitrophenyl)piperazin-1-ylethylamine and 1-phenyl-5-(2-furyl)pyrazole-3-carbaldehyde were used.
출처 및 근거
- ORD 기록
- ord-56a5dccf202c4d88998ab01780f5e205
- 출처 데이터셋
- uspto-grants-2009_06